
The Cardioprotective Effects of SS-31 Peptide: Targeting Mitochondrial Dysfunction
Mitochondrial dysfunction is increasingly recognized as a central factor in the pathogenesis of cardiovascular diseases (CVD), particularly in conditions such as heart failure, myocardial ischemia-reperfusion



